XML 21 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2012
Income Taxes [Abstract]  
Provision (benefit) for income taxes from continuing operations
The benefit for income taxes from continuing operations consists of:

 
 
Year ended December 31,
 
 
 
(in thousands)
 
 
 
2012
 
 
2011
 
 
 
 
 
 
Current income tax:
 
 
 
 
Federal
 
$
(206
)
 
$
(198
)
State
 
 
160
 
 
 
153
 
Foreign
 
 
582
 
 
 
437
 
 
 
 
536
 
 
 
392
 
Deferred income tax:
 
 
 
 
 
 
 
 
Federal
 
 
(1,650
)
 
 
(7,777
)
State
 
 
(300
)
 
 
(55
)
 
 
 
(1,950
)
 
 
(7,832
)
Benefit for income taxes
 
$
(1,414
)
 
$
(7,440
)
Deferred tax liabilities (assets)
Deferred tax liabilities (assets) are comprised of the following at:

 
 
December 31,
 
 
 
(in thousands)
 
 
 
2012
 
 
2011
 
 
 
 
 
 
Deferred tax liabilities:
Software development costs
 
$
3,740
 
 
 $
4,003
 
Gross deferred tax liabilities
 
 
3,740
 
 
 
4,003
 
 
 
 
 
 
 
 
 
 
Deferred tax assets:
Allowances for bad debts and inventory
 
 
(3,640
)
 
 
(6,608
)
Capitalized inventory costs
 
 
(125
)
 
 
(107
)
Intangible assets
 
 
(4,119
)
 
 
(4,792
)
Employee benefit accruals
 
 
(1,805
)
 
 
(1,848
)
Federal net operating loss carryforward
 
 
(8,122
)
 
 
(3,722
)
State net operating loss carryforward
 
 
(957
)
 
 
(493
)
Tax credit carryforwards
 
 
(4,006
)
 
 
(3,879
)
Foreign currency
 
 
(147
)
 
 
(191
)
Other
 
 
(334
)
 
 
(361
)
Gross deferred tax assets
 
 
(23,255
)
 
 
(22,001
)
 
 
 
 
 
 
 
 
 
Less valuation allowance
 
 
2,198
 
 
 
2,153
 
 
 
 
 
 
 
 
 
 
Net deferred tax assets
 
 $
(17,317
)
 
 $
(15,845
)
Effective income tax rate reconciliation
 
 
Year ended December 31,
 
 
 
2012
 
 
2011
 
Federal statutory tax rate
 
 
(35.0
)%
 
 
(35.0
)%
State taxes
 
 
(6.2
)
 
 
0.3
 
Non deductible expenses
 
 
6.4
 
 
 
0.7
 
Tax credits
 
 
0.0
 
 
 
(2.9
)
Foreign subsidiary liquidation
 
 
(6.3
)
 
 
0.0
 
Foreign income tax rate differential
 
 
(5.8
)
 
 
(0.3
)
Valuation allowance
 
 
1.3
 
 
 
0.9
 
Other
 
 
1.1
 
 
 
0.5
 
 
 
 
(44.5
)%
 
 
(35.8
)%